Navigation Links
World Renowned Hand Surgeon Helps Patients 'Conquer' Joint Discomfort Naturally

Dr. Joseph E. Kutz recommends Conquer HA(TM) natural Hyaluronic Acid

Formula to patients suffering from symptoms of arthritis.

LEXINGTON, Ky., June 18 /PRNewswire/ -- Renowned surgeon and co-founder of Kleinert Kutz Hand Care Center in Louisville, KY, Dr. Joseph E. Kutz has specialized in hand and reconstructive microsurgery for over four decades. Every year he sees a tremendous number of patients, from youths to seniors, suffering from arthritis or symptoms associated with arthritis. Recently he's been encouraging those patients to try an all natural Hyaluronic Acid supplement called Conquer HA(TM).

Hyaluronic Acid, or HA, is a natural lubricant that can be found in all connective tissue, joints, body cavities, joint spaces, and tissue surfaces. As a person ages or experiences injury, the HA levels in the human body become depleted, reducing lubrication in the joint.

"The one thing I tell my patients is that HA supplements, like Conquer HA(TM), are needed to maintain the proper lubrication level in the joints," said Kutz.

The Hyaluronic Acid in Conquer HA's(TM) patented formula is derived through a natural bio-fermentation process in an FDA approved facility. Conquer HA(TM) supplements are safe and have no known side effects.

"I have also recommended Glucosamine and Chondroitin sulfate to patients in the past, but found that some have experienced gastric problems. In changing them over to Conquer HA(TM), they maintain the same benefit without the gastric upset," said Kutz.

Dr. Kutz often sees patients who are long-time sufferers of arthritis. According to Kutz, "The worst thing that people do is they don't respect the early symptoms of stiffness. They think they have arthritis and feel that there is nothing they can do about it. However, we have found that the earlier people start taking supplements, the more their symptoms can be delayed."

Dr. Kutz himself has been taking Conquer HA(TM) for several years. "I have been taking Conquer HA(TM) for about four years and it's been highly effective for me and my patients, relieving symptoms, increasing joint mobility and improving the use of our hands."

In addition to being the co-founder of Kleinert Kutz, Dr. Kutz is the Chairman for the Division of Hand Surgery at the University of Louisville, School of Medicine. He is a past president of the Greater Louisville Medical Society, the American Society for Reconstructive Microsurgery, and the medical staff at Jewish Hospital in Louisville. Dr. Kutz has also published over 75 research studies in his field.

Conquer HA(TM) is a produced by HA Concepts, Inc., which is based in Lexington, KY. The company offers a wide range of joint relief solutions as well general wellness products. See

For additional information on HA Concepts, Inc. or Conquer HA please contact Melissa McDermott by telephone at (859) 246-1732 (ext 32) or by email at

SOURCE HA Concepts, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. WorldHeart Appoints David Pellone Chief Financial Officer
2. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
3. Kingfisher Healthcare (KFH) Achieves World Class Quality Platform
4. Data from Patient Subsets of e-HEALING, a Worldwide Registry, Support Use of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) as Alternative to Drug- Eluting Stents
5. National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Childrens Fitness
6. Hundreds of RNs from Across U.S. and World to Join California Nurses Association/NNOC National Convention
7. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
8. Depression May Be Worlds Most Disabling Disease
9. Concentra Opens On-Site Medical Unit at World Trade Center Site
10. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
11. Womens World Banking Welcomes New Network Member From Tunisia
Post Your Comments:
(Date:6/27/2016)... Aliso Viejo, California (PRWEB) , ... June 27, 2016 , ... ... that are fully customizable inside of Final Cut Pro X," said Christina Austin - ... with another unique style. Final Cut Pro X users can now reveal ...
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: